Information technology in mental health
ISRCTN | ISRCTN74919979 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN74919979 |
Secondary identifying numbers | 207384 |
- Submission date
- 07/12/2009
- Registration date
- 07/01/2010
- Last edited
- 11/09/2012
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Prof Maritta Välimäki
Scientific
Scientific
Department of Nursing Science
Turku
20014
Finland
Phone | +358 (0)2 333 8495 |
---|---|
mava@utu.fi |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet (Finnish only) |
Scientific title | Evaluation of internet-based patient support system in mental health care: a randomised controlled cost-effectiveness analysis |
Study acronym | Mieli.Net |
Study objectives | 1. Does information technology (IT) affect patients' insight, quality of life, symptoms, compliance, knowledge of illness and its treatment, support treatment satisfaction, and independence or shore up opportunities for psychosocial functioning more effectively than written patient information or traditional information methods? 2. Does the use of IT in clinical practice improve the staffs' knowledge level and IT-related skills, attitudes towards technology use or affect staff co-operation and working methods? 3. What are the short and long-run costs of IT compared with written material and traditional methods used in clinical practice and does IT benefit the health care organisation and society more than the two other methods from the viewpoint of cost-effectiveness? |
Ethics approval(s) | Ethics Committee of Pirkanmaa Hospital District approved on the 13th December 2004 (ref: ETL R01181) |
Health condition(s) or problem(s) studied | Schizophrenia, schizotypal disorders or delusional disorders |
Intervention | Staff in Group X will receive education (basic/advanced groups) on how to use computers, access internet-based services, and use IPSS during their educational sessions with patients. Only nurses in Group X have access to IPSS to avoid inter-group contamination. Staff in Group Y will be educated to manage education sessions with written/oral material only. In patient groups, Intervention Group A will receive need-based computerised information during discussions with a staff member with five technology sessions each lasting about 20 - 60 minutes roughly twice a week. At the end of the session, patients will receive individualised leaflets. They will also be instructed on how to use IPSS after discharge. Patients in Comparison Group B will have five oral sessions on their education programs (no use of IT). The content, number and length of the sessions is the same as in Group A. Patients in Control Group C will receive standard care, i.e. no educational sessions will be offered and they receive written information (e.g. leaflets) according to ward standards. Total duration of intervention was all together five education sessions after baseline measurement during one month and 1 - 2 sessions/week. Total duration of follow-up for all arms was 12 months. |
Intervention type | Other |
Primary outcome measure | Insight: The Schedule for the Assessment of Insight (SAI), measured at baseline (BL), 1, 3, 6 and 12 months |
Secondary outcome measures | 1. Quality of Life: Quality of life (the Quality of Well-Being, the Health Utilities Index, EQ-5D) and the Manchester Quality of Life Instrument (MANSA), measured at BL, 1, 3, 6 and 12 months 2. Symptoms: Semi-structured interview addressing psychiatric symptoms (Positive and Negative Syndrome Scale [PANNS]), measured at BL, 1, 3, 6 and 12 months 3. Compliance: Patients' compliance with treatment, patients' compliance with medication (Drug Attitude Inventory [DAI]), measured at BL, 1, 3, 6 and 12 months 4. Follow-up of medication adherence and treatment appointments (analysis of medical records) 5. Knowledge about illness and treatment: Knowledge test, measured at BL, 1, 3, 6 and 12 months 6. Treatment satisfaction during discharge process (Client Satisfaction Questionnaire-8 [CSQ-8]), measured at BL and before discharge 7. Disability and psychosocial functioning: symptoms disturbing work, social life, and family responsibilities (Sheehan Disability Scale) and the Global Assessment of Functional Scale (GAF), measured at BL, 1, 3, 6 and 12 months In addition, drop-outs in each arm were analysed to estimate the acceptance of the interventions. |
Overall study start date | 14/03/2005 |
Completion date | 04/10/2007 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Sex | Both |
Target number of participants | 300 |
Key inclusion criteria | 1. Aged 18 - 65 years, either sex 2. Diagnosis of schizophrenia, schizotypal disorders or delusional disorders (chapters F20 - F29, International Classification of Disease, version 10 [ICD-10]) |
Key exclusion criteria | 1. Unable to use the Finnish language 2. Unable to give written informed consent to participate |
Date of first enrolment | 14/03/2005 |
Date of final enrolment | 04/10/2007 |
Locations
Countries of recruitment
- Finland
Study participating centre
Department of Nursing Science
Turku
20014
Finland
20014
Finland
Sponsor information
Academy of Finland (Finland)
Government
Government
Vilhonvuorenkatu 6
PL 99
Helsinki
00501
Finland
Website | http://www.aka.fi/en-gb/A/ |
---|---|
https://ror.org/05k73zm37 |
Funders
Funder type
Government
The Academy of Finland (Finland) (ref: 207384)
No information available
The Jalmari and Rauha Ahokas Foundation (Finland)
No information available
The Finnish Cultural Foundation Uusimaa Regional Fund (Finland)
No information available
The Hospital District of Helsinki and Uusimaa (Finland)
No information available
The Pirkanmaa Hospital District (Finland)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 01/06/2012 | Yes | No |